Marker Therapeutics, Inc. (MRKR) - Cash on Hand per Share

Symbol and logo of brand Marker Therapeutics, Inc. (MRKR)

The cash per share trend reported by the GURU.Markets portal shows a recent value recorded as 0.56. The financial stability of Marker Therapeutics (MRKR) is currently entirely tied to the success of clinical trials, as the company generates no operating income. Marker Therapeutics is scaling its T-cell therapy platform supported by grants, partially outsourcing trial execution and logistics to specialized third-party contractors.

markertherapeutics.com (MRKR) - Cash per Single Share from 07/04/2022 to 11/21/2026

Comprehensive metric breakdowns and analytics for markertherapeutics.com (MRKR)

- market capitalization indicators:
Summary company analysis:MRKR (Marker Therapeutics Inc)
Finished products of Marker Therapeutics

The metric is calculated by dividing total cash and cash equivalents by the number of shares outstanding. This metric determines the actual financial foundation, stripping the analysis of market noise and the illusions of short-term trends. For Marker Therapeutics (MRKR), with its high R&D costs and lack of operating leverage, this is a critical survival indicator. The trend in cash per share demonstrates the company's ability to fund clinical trials without emergency equity offerings.